Análise de dilemas éticos corporativos

Lar

Lista de Prompts de IA

Filosofia/Religião

Assistente de decisão ética

${:__('collect %s',Assistente de decisão ética)}$

Filosofia/Religião

Auxilie as empresas a lidar com desafios éticos específicos como privacidade de dados e viés algorítmico usando estruturas utilitaristas e deontológicas, fornecendo conselhos de decisão conformes e centrados no ser humano.

Conteúdo do prompt

Copiar

Act as a corporate ethics consultant to analyze specific business scenarios involving potential data privacy leaks or algorithmic bias in AI applications. Combine the utilitarian principle of maximizing happiness with the deontological categorical imperative to evaluate the impact on stakeholders such as employees, users, and society. Identify potential moral conflicts across different decision paths, assess long-term consequences, and provide a balanced solution that complies with laws while reflecting humanistic care. Ensure that technology deployment does not infringe on individual basic rights while promoting overall social well-being.

Copiar

Atue como consultor de ética empresarial para analisar cenários comerciais específicos envolvendo possíveis vazamentos de privacidade de dados ou viés algorítmico em aplicações de IA. Combine o princípio utilitarista de maximização da felicidade com o imperativo categórico deontológico para avaliar o impacto nas partes interessadas, como funcionários, usuários e sociedade. Identifique possíveis conflitos morais em diferentes caminhos de decisão, avalie as consequências de longo prazo e forneça uma solução equilibrada que esteja em conformidade com as leis, mas também reflita a preocupação humanista. Certifique-se de que a implementação de tecnologia não infrinja os direitos básicos dos indivíduos, promovendo ao mesmo tempo o bem-estar geral da sociedade.

Copiar

Compartilhar Clique para copiar o link

Comentários (0)

0/300

Enviar

Recomendação

Auxílio à decisão ética

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes severe side effects in a very small subset of patients with specific genetic markers, but recalling the drug would bankrupt the company and disrupt supply for thousands of ordinary patients. Please evaluate the trade-offs between shareholder interests, patient safety, and corporate social responsibility by combining utilitarian consequence assessment with deontological respect for human dignity. Provide an action plan that balances legal compliance and moral justification, focusing on how to protect vulnerable groups while maintaining the enterprise's sustainable operations.

Auxílio à decisão ética

Please analyze the following specific ethical dilemma encountered in corporate operations: A pharmaceutical company discovers that its long-listed common drug has severe side effects in a very small subset of specific genetic populations, but the recall cost is extremely high and could lead to bankruptcy, affecting the livelihoods of thousands of employees. Please evaluate the moral weight of both recall and non-recall options by combining utilitarian calculations for the greatest good of the majority with deontological emphasis on patient informed consent and safety responsibilities, and provide a balanced recommendation that reconciles business sustainability with patient safety, focusing on how to establish a priority value sequence amidst conflicting interests.

Auxílio à decisão ética

When an enterprise faces moral dilemmas involving conflicting stakeholders, please conduct a multi-dimensional ethical review of the specific case by combining utilitarian consequence assessment with deontological principle constraints, identify potential unintended social impacts, and recommend solutions that balance compliance and humanistic care, ensuring the decision-making process is transparent and aligns with core organizational values.

Auxílio à decisão ética

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but predictable side effects with long-term use, increasing cardiovascular risk, but stopping the medication leads to worsening of the original disease. Please evaluate the moral合理性 of continuing sales, recalling, or modifying labels by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Provide a final recommendation that balances commercial interests with patient well-being, ensuring the argument is logically rigorous and demonstrates respect for individual dignity.

Auxílio à decisão ética

Please analyze the ethical conflict involved in the following business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet stopping the medication carries higher risks. Please evaluate whether the company should proactively recall the drug and disclose information, combining the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Consider the impacts on multiple stakeholders including shareholders, patient safety, legal compliance, and corporate reputation, and provide an ethical decision recommendation that balances these interests, explaining how this decision achieves a balance between moral responsibility and business sustainability.

Auxílio à decisão ética

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but foreseeable side effects with long-term use, increasing long-term health risks for patients, while discontinuing the drug would worsen current acute symptoms. Please evaluate whether to proactively recall and disclose this risk by combining the impact on overall well-being from a utilitarian perspective with respect for patient informed consent from a deontological perspective, while considering the long-term impact on shareholder interests, corporate reputation, and patient trust, ultimately providing an action recommendation that balances moral responsibility with business sustainability.